Linkedin
Agilent Technologies announced in July 2017 that Ram Sasisekharan, Ph.D. is the recipient of an Agilent Thought Leader Award in recognition of his contributions in the biologics characterization field.
Since the usual timeframe, from discovery to human clinical trials, to develop biopharmaceuticals can be up to several years, more efficient development of monoclonal antibodies (mAbs) against cancer targets and emerging pathogens is becoming critical. This award will help Dr. Sasisekharan and his lab at the Massachusetts Institute of Technology (MIT) continue to evolve their approach, which aims to shorten the development time between product ‘design’...
Agilent Technologies Presents Thought Leader Award to Dr. Ram Sasisekharan
Agilent Technologies announced in July 2017 that Ram Sasisekharan, Ph.D. is the recipient of an Agilent Thought Leader Award in recognition of his contributions in the biologics characterization field.
Since the usual timeframe, from discovery to human clinical trials, to develop biopharmaceuticals can be up to several years, more efficient development of monoclonal antibodies (mAbs) against cancer targets and emerging pathogens is becoming critical. This award will help Dr. Sasisekharan and his lab at the Massachusetts Institute of Technology (MIT) continue to evolve their approach, which aims to shorten the development time between product ‘design’...